Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Adverum Biotechnologies Inc (ADVM)

Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri May 2, 3:01PM CDT

ADVM : 2.71 (-3.56%)
Adverum Biotechnologies: Q4 Earnings Snapshot AP - Tue Apr 15, 6:49AM CDT

Adverum Biotechnologies: Q4 Earnings Snapshot

ADVM : 2.71 (-3.56%)
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones GlobeNewswire - Tue Apr 15, 6:40AM CDT

ADVM : 2.71 (-3.56%)
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Apr 4, 3:05PM CDT

ADVM : 2.71 (-3.56%)
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference GlobeNewswire - Mon Mar 31, 3:01PM CDT

ADVM : 2.71 (-3.56%)
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD GlobeNewswire - Mon Mar 3, 3:01PM CST

ADVM : 2.71 (-3.56%)
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Feb 28, 3:00PM CST

ADVM : 2.71 (-3.56%)
Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference GlobeNewswire - Tue Feb 25, 6:00AM CST

ADVM : 2.71 (-3.56%)
Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference GlobeNewswire - Wed Feb 5, 3:05PM CST

ADVM : 2.71 (-3.56%)
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Dec 6, 2024

ADVM : 2.71 (-3.56%)

Barchart Exclusives

Worried About Stagflation? These 3 Top-Rated Dividend Stocks Are ‘Strong Buys.’ Barchart - Mon May 12, 6:30PM CDT
These companies have resilient business models, strong dividend yields, and analyst support. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot